A trial looking at chemotherapy before a stem cell transplant for children with acute myeloid leukaemia (MyeChild01)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Children's cancers, Leukaemia, Myelodysplastic syndrome (MDS)

Status:

Closed

Phase:

Phase 3

Details

This trial is for children and young people with leukaemia that has a high risk of coming back after treatment. It is open to children and young people with:

acute myeloid leukaemia (AML)
high risk myelodysplastic syndrome (MDS)
an isolated myeloid sarcoma (granulocytic sarcoma)

This summary is 1 of 3 summaries of the MyeChild01 trial. We have information on:

Cancer Research UK supports the MyeChild01 trial.

This study is for children and young people who haven’t reached their 18th birthday. We use the term ‘you’ in the summary but if you are a parent we are referring to your child.

Recruitment start: 29 April 2016

Recruitment end: 28 June 2022